PT Kalbe Farma Tbk. (PTKFF)
OTCMKTS · Delayed Price · Currency is USD
0.0626
-0.0332 (-34.66%)
At close: Sep 3, 2025
PT Kalbe Farma Tbk. Revenue
PT Kalbe Farma Tbk. had revenue of 8.23T IDR in the quarter ending June 30, 2025, with 3.37% growth. This brings the company's revenue in the last twelve months to 33.38T, up 5.63% year-over-year. In the year 2024, PT Kalbe Farma Tbk. had annual revenue of 32.63T with 7.16% growth.
Revenue (ttm)
33.38T IDR
Revenue Growth
+5.63%
P/S Ratio
1.60
Revenue / Employee
2.59B IDR
Employees
12,903
Market Cap
3.28B USD
Revenue Chart
* This company reports financials in IDR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.63T | 2,178.64B | 7.16% |
Dec 31, 2023 | 30.45T | 1,515.63B | 5.24% |
Dec 31, 2022 | 28.93T | 2,672.31B | 10.18% |
Dec 31, 2021 | 26.26T | 3,148.54B | 13.62% |
Dec 31, 2020 | 23.11T | 479.18B | 2.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |